Summary
A mouse L1210 leukemia cell line was made 25-fold resistant to methotrexate (MTX) and had altered methionine transport and metabolism. L1210 cells resistant to methotrexate also had a 50-fold decrease in the exogenous methionine requirement for optimal cell growth compared to the parent cells. This change in methionine requirement was associated with differences in methionine metabolism between MTX-sensitive and MTX-resistant cell lines. Analysis of amino acid transport systems revealed different K1 and Vmax properties of methionine and nonmetabolizable amino acid analogues. There was a greater than twofold decrease in the initial sodium-dependent uptake of methionine in the resistant cells. Amino acid competition experiments revealed altered substrate specificities in the resistant cells. The cellular alterations occurring upon resistance may result from methotrexatemembrane interactions, and have been previously observed in cisplatinum-resistant cells. Thus modulation of methionine metabolism may provide the biochemical basis for MTX and cisplatinum collateral resistance.
Similar content being viewed by others
References
Bertino JR (1978) Resistance of human tumors to cancer chemotherapeutic agents: an important research problem. Med Pediatr Oncol 5:105
Chello PL, McQueen CA, DeAngelis LM, Bertino JR (1976) Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists. Cancer Res 36:2442
Christensen HN (1982) Interorgan amino acid nutrition. Nutr Physiol Rev 62:1193–1233
Coward JK, Chello PL, Cashmore AR, Parameswaran KN, DeAngelis LM, Bertino JR (1975) 5-Methyl-5, 6, 7, 8-tetrahydropteroyl oligo-gamma-L-glutamates: synthesis and kinetics studies. Biochem 14:1548
Goldman ID, Lichtenstein NS, Oliverio VT (1968) Carriermediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell. J Biol Chem 213:5007
Gross RB, Scanlon KJ (1986) Amino acid membrane transport properties of L1210 cells resistant to cisplatin. Chemioterapia 5:37
Handlogten ME, Garcia-Canero R, Lancaster KT, Christensen HN (1981) Surprising differences in substrate selectivity and other properties of systmes A and ASC between rat hepatocytes and the hepatoma cell line, HTC. J Biol Chem 256: 7905
Hickman JA, Scanlon KJ, Tritton TR (1984) Membrane targets in cancer chemotherapy. Trends Pharmacol Sci 5:15
Hoffman RM (1981) Methionine dependence in cancer cells. A review. In Vitro 18:421
Nixon PF, Slutsky G, Nahas A, Bertino JR (1973) The turnover of folate coenzymes in murine lymphoma cells. J Biol Chem 248:5932
Scanlon KJ, Moroson BA, Hynes JB, Bertino JR (1979) Quinazoline analogues of folic acid as inhibitors of thymidylate synthetase from bacteria and mammalian sources. Mol Pharmacol 16:261
Scanlon KJ, Cashmore AR, Moroson BA, Dreyer RN, Bertino JR (1981) Inhibition of serine metabolism by tetrahydrohomofolate in L1210 mouse leukemia cells. Mol Pharmacol 19:481
Scanlon KJ, Berkowitz K, Pallai ME, Waxman S (1983) Inhibition of amino acid transport by methotrexate in stimulated human lymphocytes. Cancer Treat Rep 67:631
Scanlon KJ, Reigelhaupt R, Pallai M, Kisthard H, Kassan S, Waxman S (1983) Altered methotrexate sensitivity in human leukemic K562 amino acid transport mutant cells. In: Blair JA (ed) Chemistry and biology of pteridines, Vol 5. de Guyter, Berlin, p 933
Scanlon KJ, Safirstein R, Thies H, Gross RB, Waxman S, Guttenplan J (1983) Inhibition of amino acid transport by cisplatin and its derivatives in L1210 murine leukemia cells. Cancer Res 43:4211
Schabel FM, Skipper HE, Trader MW, Laster WR, Griswold DP, Corbett TH (1983) Establishment of cross-resistance profiles for new agents. Cancer Treat Rep 67:905
Shionoya S, Lu Y, Scanlon KJ (1986) Properties of amino acid transport systems in K562 cells sensitive and resistant to cisdiamminedichloroplatinum (II). Cancer Res 46:3445
Teicher BA, Cucchi CA, Lee JB, Flatow JL, Rosowsky A, Frei E (1986) Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Cancer Res 46: 4379–4386
Author information
Authors and Affiliations
Additional information
This work is supported by the American Cancer Society Grant (CH-265), USPHS CA 08010 and CA 16359, and the Chemotherapy Foundation, Inc.
Kevin J. Scanlon is a Scholar of the Leukemia Society of America
Rights and permissions
About this article
Cite this article
Scanlon, K.J., Kashani-Sabet, M., Cashmore, A.R. et al. The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cells. Cancer Chemother. Pharmacol. 19, 25–29 (1987). https://doi.org/10.1007/BF00296250
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00296250